Kezar Life Sciences Inc (KZR) financials · $53.9M cap
Kezar Life Sciences Inc (KZR) $53.9M cap.
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Revenue | — | — | |
| Operating Income | −$59.11M | −$90.61M | |
| Net Income | −$56.03M | −$83.74M | |
| EPS (Diluted) | −$7.66 | −$11.49 | |
| Unlock 5 years of statements: Lician Pro $149/yr | |||
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $76.65M | $144.68M | |
| Current Assets | $75.73M | $137.49M | |
| Cash & Equivalents | $71.88M | $41.75M | |
| PP&E | $166.00K | $2.89M | |
| Total Liabilities | $6.57M | $27.77M | |
| Current Liabilities | $6.57M | $20.33M | |
| Short-term Debt | — | $5.22M | |
| Long-term Debt | — | $5.11M | |
| Total Debt | — | $10.33M† | |
| Shareholders' Equity | $70.07M | $116.92M | |
| Retained Earnings | −$490.53M | −$434.50M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | −$51.78M | −$74.21M | |
| CapEx | $8.00K | $29.00K | |
| Investing Cash Flow | $92.46M | $80.43M | |
| Financing Cash Flow | −$10.59M | $103.00K | |
| Dividends Paid | $0 | $0 | |
| Net Change in Cash | $30.13M | $6.26M | |
| Free Cash Flow | −$51.78M | −$74.24M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2025
FAQ
What is KZR P/E and revenue?
Kezar Life Sciences Inc (KZR) $53.9M cap.
What is KZR revenue?
KZR income-statement cache has no revenue figure yet.
Is KZR profitable?
Kezar Life Sciences Inc last cached net income is -$56.0M (FY2025).
What are KZR total assets?
Kezar Life Sciences Inc last cached total assets are $76.6M (FY2025).
What is KZR free cash flow?
Kezar Life Sciences Inc last cached free cash flow is -$51.8M (FY2025).
Not investment advice. Figures as reported in company filings, not a live feed.